Author: OurCrowd

[Appdome in PR Newswire] Appdome releases new Defenses to combat accessibility malware

Sep 26, 2023 |

REDWOOD CITY, Calif., Sept. 26, 2023 /PRNewswire/ — Appdome, the one-stop shop for mobile app defense, today announced new mobile anti-malware protections that detect Android Accessibility Service Malware such as Xenomorph, Brasdex, Octo, Sharkbot, Flubot, TeaBot, PixPirate, Sova, Spynote, Joker and more. These malware are used to carry out large scale, distributed attacks on mobile banking apps, crypto wallets, and other financial services apps. Read...

Read More

[Swiftly in PR Newswire] Swiftly bolsters C Suite with key leadership appointments

Sep 26, 2023 |

SEATTLE, Sept. 26, 2023 /PRNewswire/ — Swiftly®, a best-in-class technology company that delivers omnichannel tools for retailers, today announced the expansion of its leadership team through the appointments of Karen Short as Board Member and Claire Ko as Chief People Officer. Their strategic addition to the company underscores Swiftly’s commitment to propelling innovation, accommodating growth and cultivating an expansive portfolio. Read more...

Read More

[InsideTracker in FemTech Insider] InsideTracker unveils nNew DNA insights focused on menopausal age, bone density, and more

Sep 26, 2023 |

InsideTracker, a personalized health and wellness company, has announced a major update with the release of 10 new healthspan-focused DNA insights. This update, which includes pivotal information on menopausal age and bone density, offers a comprehensive health profile for individuals, providing actionable insights on a range of genetic indicators. Read more...

Read More

[Alloy Therapeutics in PR Newswire] Partillion Bioscience Corporation announces seed financing, expanded board, and new partnership with Alloy Therapeutics

Sep 26, 2023 |

LOS ANGELES, Sept. 26, 2023 /PRNewswire/ — Partillion Bioscience Corporation (“Partillion”), a life science tools company, today announced the closing of a $5 million seed financing round, expansion of its board of directors, and a multiyear agreement with Alloy Therapeutics, Inc. as a Preferred Partner providing antibody discovery services using Partillion’s Nanovial technology. Nanovials solve numerous industry challenges as the first microscale test tubes engineered for the isolation and analysis of individual cells that are compatible with standard laboratory equipment.  Read...

Read More